5 Stocks Pushing The Health Services Industry Lower

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 46 points (-0.4%) at 12,524 as of Thursday, Nov. 15, 2012, 12:05 PM ET. The NYSE advances/declines ratio sits at 826 issues advancing vs. 2,151 declining with 91 unchanged.

The Health Services industry currently sits down 0.7% versus the S&P 500, which is down 0.5%. On the negative front, top decliners within the industry include Mindray Medical International ( MR), down 2.5%, Cooper Companies ( COO), down 1.5%, HCA Holdings ( HCA), down 1.2% and Thermo Fisher Scientific ( TMO), down 0.9%.

TheStreet Ratings group would like to highlight 5 stocks pushing the industry lower today:

5. Hologic ( HOLX) is one of the companies pushing the Health Services industry lower today. As of noon trading, Hologic is down $0.23 (-1.2%) to $19.63 on light volume Thus far, 709,921 shares of Hologic exchanged hands as compared to its average daily volume of 2.2 million shares. The stock has ranged in price between $19.52-$19.90 after having opened the day at $19.83 as compared to the previous trading day's close of $19.86.

Hologic Inc. develops, manufactures, and supplies diagnostic, medical imaging systems, and surgical products for the healthcare needs of women. The company operates in four segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. Hologic has a market cap of $5.4 billion and is part of the health care sector. The company has a P/E ratio of 14.7, below the S&P 500 P/E ratio of 17.7. Shares are up 15.6% year to date as of the close of trading on Wednesday. Currently there are 16 analysts that rate Hologic a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Hologic as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income and weak operating cash flow. Get the full Hologic Ratings Report now.

4. As of noon trading, Life Technologies ( LIFE) is down $0.43 (-0.9%) to $45.99 on light volume Thus far, 216,031 shares of Life Technologies exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $45.67-$46.47 after having opened the day at $46.36 as compared to the previous trading day's close of $46.42.

Life Technologies Corporation operates as a global life sciences company. Life Technologies has a market cap of $8.1 billion and is part of the health care sector. The company has a P/E ratio of 20.5, above the S&P 500 P/E ratio of 17.7. Shares are up 20.6% year to date as of the close of trading on Wednesday. Currently there are 10 analysts that rate Life Technologies a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Life Technologies as a buy. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations, solid stock price performance, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Life Technologies Ratings Report now.

3. As of noon trading, Varian Medical Systems ( VAR) is down $0.49 (-0.7%) to $67.26 on light volume Thus far, 236,770 shares of Varian Medical Systems exchanged hands as compared to its average daily volume of 1.0 million shares. The stock has ranged in price between $67.25-$68.20 after having opened the day at $67.80 as compared to the previous trading day's close of $67.75.

Varian Medical Systems, Inc. designs, manufactures, sells, and services equipment and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy, stereotactic radiosurgery, and brachytherapy worldwide. Varian Medical Systems has a market cap of $7.6 billion and is part of the health care sector. The company has a P/E ratio of 18.2, above the S&P 500 P/E ratio of 17.7. Shares are up 1.7% year to date as of the close of trading on Wednesday. Currently there are 8 analysts that rate Varian Medical Systems a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates Varian Medical Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and increase in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Varian Medical Systems Ratings Report now.

2. As of noon trading, Zimmer Holdings ( ZMH) is down $0.56 (-0.9%) to $63.78 on light volume Thus far, 365,896 shares of Zimmer Holdings exchanged hands as compared to its average daily volume of 1.3 million shares. The stock has ranged in price between $63.56-$64.42 after having opened the day at $64.32 as compared to the previous trading day's close of $64.34.

Zimmer Holdings, Inc., through its subsidiaries, engages in the design, development, manufacture, and marketing of orthopedic reconstructive devices, spinal and trauma devices, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific. Zimmer Holdings has a market cap of $11.2 billion and is part of the health care sector. The company has a P/E ratio of 15.0, below the S&P 500 P/E ratio of 17.7. Shares are up 20.6% year to date as of the close of trading on Wednesday. Currently there are 12 analysts that rate Zimmer Holdings a buy, no analysts rate it a sell, and 13 rate it a hold.

TheStreet Ratings rates Zimmer Holdings as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Zimmer Holdings Ratings Report now.

1. As of noon trading, Intuitive Surgical ( ISRG) is down $4.35 (-0.8%) to $522.11 on light volume Thus far, 73,743 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 355,300 shares. The stock has ranged in price between $521.85-$529.00 after having opened the day at $526.50 as compared to the previous trading day's close of $526.46.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems for various surgical procedures, including urologic, gynecologic, cardiothoracic, general, and head and neck surgeries. Intuitive Surgical has a market cap of $21.3 billion and is part of the health care sector. The company has a P/E ratio of 34.6, above the S&P 500 P/E ratio of 17.7. Shares are up 13.7% year to date as of the close of trading on Wednesday. Currently there are 6 analysts that rate Intuitive Surgical a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Intuitive Surgical Ratings Report now.

If you are interested in one of these 4 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

null

More from Markets

Ackman Investment Buoys Lowe's; DraftKings Responds to FanDuel Merger -- ICYMI

Ackman Investment Buoys Lowe's; DraftKings Responds to FanDuel Merger -- ICYMI

Replay: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Replay: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Red Robin Slumps After Earnings Miss

Red Robin Slumps After Earnings Miss

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet